Show simple item record

dc.contributorWichita State University. Department of Chemistryen_US
dc.contributor.authorLi, Yien_US
dc.contributor.authorDou, Dengfengen_US
dc.contributor.authorHe, Guijiaen_US
dc.contributor.authorLushington, Gerald H.en_US
dc.contributor.authorGroutas, William C.en_US
dc.date.accessioned2012-02-06T17:16:05Z
dc.date.available2012-02-06T17:16:05Z
dc.date.issued2009-05-15en_US
dc.identifier19394830en_US
dc.identifier9413298en_US
dc.identifierS0968-0896(09)00355-1en_US
dc.identifierHL 57788/ R01 HL057788-08en_US
dc.identifier.citationBioorganic & medicinal chemistry. 2009 May 15; 17(10): 3536-42.en_US
dc.identifier.issn1464-3391en_US
dc.identifier.issn0968-0896en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.bmc.2009.04.011en_US
dc.identifier.urihttp://hdl.handle.net/10057/4305
dc.descriptionClick on the DOI link below to access the article.en_US
dc.description.abstractA series of mechanism-based inhibitors designed to interact with the S' subsites of serine proteases was synthesized and their inhibitory activity toward the closely-related serine proteases human neutrophil elastase (HNE) and proteinase 3 (PR 3) was investigated. The compounds were found to be time-dependent inhibitors of HNE and were devoid of any inhibitory activity toward PR 3. The results suggest that highly selective inhibitors of serine proteases whose primary substrate specificity and active sites are similar can be identified by exploiting differences in their S' subsites. The best inhibitor (compound 16) had a k(inact)/K(I) value of 4580 M(-1)s(-1).en_US
dc.description.sponsorshipNHLBI NIH HHS/ NHLBI NIH HHSen_US
dc.format.extent3536-42en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesBioorganic & medicinal chemistryen_US
dc.relation.ispartofseriesBioorg. Med. Chem.en_US
dc.sourceNLMen_US
dc.subjectResearch Support, N.I.H., Extramuralen_US
dc.subject.meshBinding Sitesen_US
dc.subject.meshComputer Simulationen_US
dc.subject.meshDrug Designen_US
dc.subject.meshHumansen_US
dc.subject.meshLeukocyte Elastase/antagonists & inhibitorsen_US
dc.subject.meshMyeloblastin/antagonists & inhibitorsen_US
dc.subject.meshProtein Structure, Tertiaryen_US
dc.subject.meshSerine Endopeptidases/chemistryen_US
dc.subject.meshSerine Proteinase Inhibitors/chemical synthesisen_US
dc.subject.meshStructure-Activity Relationshipen_US
dc.subject.meshSubstrate Specificityen_US
dc.subject.meshThiadiazoles/chemical synthesisen_US
dc.subject.meshLeukocyte Elastase/metabolismen_US
dc.subject.meshMyeloblastin/metabolismen_US
dc.subject.meshSerine Endopeptidases/metabolismen_US
dc.subject.meshSerine Proteinase Inhibitors/chemistryen_US
dc.subject.meshSerine Proteinase Inhibitors/pharmacologyen_US
dc.subject.meshThiadiazoles/chemistryen_US
dc.subject.meshThiadiazoles/pharmacologyen_US
dc.titleMechanism-based inhibitors of serine proteases with high selectivity through optimization of S' subsite bindingen_US
dc.typeArticleen_US
dc.coverage.spacialEnglanden_US
dc.description.versionpeer revieweden_US
dc.rights.holderCopyright © 2009, Elsevieren_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record